Micah Niphakis Receives ACS Scarborough Award
News Jan 21, 2013
Micah Niphakis, research associate in the Cravatt lab at The Scripps Research Institute (TSRI), has received the 2013 Scarborough Graduate/Postgraduate Award for Excellence from the American Chemical Society’s Division of Medicinal Chemistry.
Named in memory of Robert M. Scarborough, medicinal chemist and inventor of drugs such as Natrecor® and Integrilin®, the award recognizes a postdoctoral researcher or graduate student who has had a leading role in scientific discoveries in the field of medicinal chemistry. Niphakis will present his research at the fall national meeting of the American Chemical Society in Indianapolis.
Niphakis and his colleagues are currently using the technology to elucidate proteins that regulate a class of neurotransmitters called endocannabinoids, which plays an important role in the regulation of inflammation, pain sensation, mood and appetite.
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Bone Cancer Drug Targets Tumors, Spares Other OrgansNews
A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018